Comparative analysis of the therapeutic effects of mifepristone with different low doses for the treatment of adenomyosis women with dysmenorrhea
陈舒宜,孙文婷,朱丽波,丁少杰,徐萍,黄秀峰,张信美
DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2016.12.001
2016-01-01
Abstract:Objective:To investigate the therapeutic effects of different low doses of mifepristone ( RU486 ) on adenomyosis women with dysmenorrhea so as to obtain an appropriate dose of RU486 for the treatment of adenomyosis. Methods:A total of 68 adenomyosis patients with dysmenorrhea were treated with 25mg RU486 weekly (group I:25mg/w,n=33),5mg RU486 daily (group II:5mg/d,n=24) and 2. 5mg RU486 daily (group III:2. 5mg/d,n=11) ,respectively. Before and after treatment,the uterine size,serum CA125 levels,VAS score, menstrual amounts,endometrial thickness and hemoglobin levels were analyzed comparatively. Results:Three and six months after treatment,the VAS scores and menstrual amounts in group I,II and III were all significantly lower than those before treatment (P<0. 05),while the hemo-globin levels were all significantly higher than those before treatment (P<0. 05). In group I,se-rum CA125 levels after treatment for 3 and 6 months were all lower than those before treatment ( P<0 . 05 ) , but no significant differences of uterine volume and endometrial thickness were found between 3 and 6 months after treatment (P>0. 05). In group II,serum CA125 levels and uterine volume after treatment for 3 months were both significantly lower than those before treat-ment(P<0. 05),and endometrial thickness after treatment for 6 months were significantly high-er than those before treatment (P<0. 05). However,serum CA125 levels or uterine volume after treatment for 6 months did not reach significant difference when compared with those before treatment(P>0. 05). In group III,serum CA125 levels and endometrial thickness after treat-ment for 6 months were both significantly higher than those before treatment (P<0. 05),but no significant difference of uterine volume between before and after treatment was found ( P>0 . 05 ) . Conclusions:These results suggest that different low doses of RU486 can be used to treat adenomyosis patients with dysmenorrhea effectively,but 25mg RU486 weekly might be the priority choice for the short-term treatment of adenomyosis with dysmenorrhea because it is con-venience,has long time interval and does not increase endometrial thickness.